Surrozen, Inc. - Common Stock (SRZN)
21.72
-1.27 (-5.52%)
NASDAQ· Last Trade: Jul 22nd, 6:20 PM EDT
Detailed Quote
| Previous Close | 22.99 |
|---|---|
| Open | 23.22 |
| Bid | 20.40 |
| Ask | 34.73 |
| Day's Range | 21.21 - 23.22 |
| 52 Week Range | 8.210 - 35.00 |
| Volume | 378,172 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 182,143 |
Chart
About Surrozen, Inc. - Common Stock (SRZN)
Consonance-HFW Acquisition Corp is a special purpose acquisition company (SPAC) that focuses on identifying and merging with innovative firms in the health and wellness sector. The company aims to provide a platform for growth and value creation by leveraging its expertise in healthcare investment, operational improvements, and strategic partnerships, ultimately seeking to transition a target company into a publicly traded entity. By facilitating these mergers, Consonance-HFW Acquisition Corp aims to drive advancements in healthcare solutions, enhance patient experiences, and contribute to the efficiency of healthcare systems. Read More
News & Press Releases
Surrozen (NASDAQ:SRZN) Chief Executive Officer Craig Parker outlined the company’s rationale for developing Wnt-targeting retinal disease therapies during H.C. Wainwright’s 6th Annual Ophthalmology Investor Conference, emphasizing the company’s focus on Frizzled-4 signaling, anti-VEGF activity and,
Via MarketBeat · July 22, 2026

Via Benzinga · January 30, 2025

Via Benzinga · January 3, 2025

SRZN stock results show that Surrozen beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 8, 2024

SRZN stock results show that Surrozen beat analyst estimates for earnings per share the second quarter of 2023.
Via InvestorPlace · December 14, 2023

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via Benzinga · April 1, 2024

Surrozen engages in a private placement, aiming to raise approximately $192.5 million in gross proceeds. Updates on SZN-043 Phase 1a trial reveal promising safety, tolerability, and effects on liver function.
Via Benzinga · April 1, 2024

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the first quarter of 2023.
Via InvestorPlace · December 14, 2023

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the third quarter of 2023.
Via InvestorPlace · December 14, 2023

Via Benzinga · December 5, 2023

Via Benzinga · November 15, 2023

Via Benzinga · September 21, 2023

Via Benzinga · August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Via Benzinga · August 10, 2023

Via Benzinga · March 23, 2023

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.
Via Benzinga · March 22, 2023

Gainers
Via Benzinga · February 10, 2023

We're starting off Friday with an overview of the biggest pre-market stock movers traders will want to keep an eye on today!
Via InvestorPlace · February 10, 2023

Via Benzinga · February 9, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.
Via Benzinga · February 9, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · January 24, 2023